Skip to content
healthcare.dev
Get a free key

XIFAXAN

NDC 65649-301, rifaximin, tablet, from Salix Pharmaceuticals, Inc..

Product NDC
65649-301
Status
Listed
Labeler
Salix Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021361
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65649-301 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIFAXIMIN200 mg/1

Pharmacologic classes

Rifamycin Antibacterial [EPC]; Rifamycins [CS]

Package NDCNDC-11Package
65649-301-036564903010330 TABLET in 1 BOTTLE (65649-301-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c5e8e2fd-7087-4b78-9181-cc259c0be2f1

Use it

Look up 65649-301 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65649-301 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65649-301. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.